Pneumococcal Capsules and Their Types: Past, Present, and Future
By K. A. Geno, Gwendolyn L. Gilbert, J. Song, I. C. Skovsted, K. Klugman, Christopher Jones, H. Konradsen, M. Nahm. Clinical Microbiology Reviews, 2015
614 citations recorded by the source corpus.
Subfields: Epidemiology
View Paper: https://www.semanticscholar.org/paper/61217647ddbc86a0d63d370ae85b90c478b0a1f0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
Citations in the corpus
- The Pangenome: Diversity, Dynamics and Evolution of Genomes (2020, background): “A current vaccine targets the 19F capsule, but not the 19A. Serotype 19F strains were widely prevalent pre-vaccine, while serotype 19A strains have spread in the USA during the post-vaccine era (Geno et al. 2015).”
- Polyamine transporter potABCD is required for virulence of encapsulated but not nonencapsulated Streptococcus pneumoniae (2017, background): “Group I includes NESp that have a mutated, dysfunctional variant of the characteristic capsule polysaccharide biosynthetic (cps) locus, while group II includes NESp whose cps genes are replaced by novel genes that code for distinct pneumococcal proteins [6,7].”
- Biological roles of glycans (2016, background): “The complexity and diversity of surface polysaccharides found on strains of a single bacterial species (>100 in the case of the pneumococcus) (843) might be explained not only by selection for evasion of the vertebrate antibody response (844), but also by the need to evade attack by environmental ba”